In addition, FAM83H expression was transcriptionally controlled by MYC in liver cancer cells [7], and FAM83H overexpression was significantly associated with KRAS mutation and EMT gene signature in pancreatic cancer [10]. This evidence concerns the gene KRAS and familial pancreatic carcinoma.